baber/WOPTO huggingface dataset:
Patent DE-69203170-D1 (DE)
Inventor: PATTERSON THOMAS C
IPC: B23K26/08
Filed: 1992-07-21
Granted: 1995-08-03
Abstract: A frame that includes first and second tubular members (12, 14, 16, 18, 20) joined at a predetermined angle to each other solely by a bond along a joint between a surface along a portion of a wall of the first member (12, 18, 20) and an edge (14E, 16E, 18E) along at least a portion of the wall of the second member is fabricated by cutting the edge of the wall of the second member at the joint being to a shape that conforms to and abuts the surface of the first member so as to establish and maintain the predetermined angle between the members. The first member is formed with a slot (12S, 18S, 20S) that registers with the edge of the second member, and the second member is formed with an integral tab (14T, 16T, 18T) along part of the edge forming the joint. The tab on the second member is received in close-fitting relation in the slot of the first member so as to establish and maintain a predetermined position of the second member axially and rotationally relative to the first member. <IMAGE>
Patent DE-69209660-D1 (DE)
Inventor: LANDRRETCHE ALAIN
IPC: B60K26/02
Filed: 1992-12-18
Granted: 1996-05-09
Abstract: PCT No. PCT/FR92/01208 Sec. 371 Date Sep. 22, 1994 Sec. 102(e) Date Sep. 22, 1994 PCT Filed Dec. 18, 1992 PCT Pub. No. WO93/12949 PCT Pub. Date Jul. 8, 1993A power control assistance device provided with an actuator mechanically connected to the power control member to provide a directly controlled returned force to the power control member in direct opposition to the force exerted by the operator.
Patent DE-69209709-D1 (DE)
Inventor: BERNARDI PAOLO
IPC: C07H15/04
Filed: 1992-04-21
Granted: 1996-05-15
Abstract: Process for the preparation of esters of carboxylic acids having the formula: <CHEM> wherein X = H, -CH2COOR; Y, Z = H, OH or together form a bond and when X =CH2COOR, Y = OH and Z = H; R, R1, R2 = H, A wherein A = monoalkyl (C6-C16) glucose or poly (2-6) glucose ether, at least one among R, R1 and R2 is = A; by means of esterification of the corresponding acid or anhydride with an alkylpolyglucoside A in the presence of a fatty alcohol (C6 - C16).
Patent DE-69231941-D1 (DE)
Inventor: HARDIE GREGORY J
IPC: C21B13/10
Filed: 1992-09-10
Granted: 2001-08-23
Abstract: A method for treating gases and solids in a fluid bed, the fluid bed reactor substantially comprising, regarded downstream, a mixing chamber (14), a riser pipe (9) and a cyclone (16) with a solids return pipe (11) to the mixing chamber (14), the gases being introduced into the mixing chamber (14) at a gas rate immediately before the inlet port (4) of the mixing chamber of more than (35) m/sec. <IMAGE>
Patent DE-69232085-D1 (DE)
Inventor: LEUNG FONG
IPC: B01D17/038
Filed: 1992-11-20
Granted: 2001-10-31
Abstract: A feed accelerator system for use in a centrifuge, the system comprising an accelerator rotatably mounted substantially concentrically within the centrifuge and including a plurality of disc members concentrically and proximately spaced having a first disc and a second disc, each disc having an inside surface and an outer edge defining a disc diameter. The second disc includes a target surface having no sharp bends or junctions. The first disc includes a disc opening for receiving a discharge opening of a feed pipe. A plurality of disc vanes are disposed between the first and second discs so as to form a plurality of feed channels. The vanes generally extend from a radius equal to or larger than that of the disc opening and of the target surface, and terminate at a radius on the inside surfaces of the first and second discs at a distance from the outer edge of at least one of the first and second discs so as to form a disc smoothener on at least one of the inside surfaces of the first and second discs. A generally cone-shaped apparatus may be attached to the respective outer edges of the first and/or second discs to further smooth the feed slurry so as to produce circumferential flow uniformity of the feed slurry entering the pool of a decanter centrifuge or impinging upon the basket of a pusher centrifuge.
Patent DE-69310146-D1 (DE)
Title: Riemenspannvorreichtung
Inventor: GARDNER DAVID
IPC: F16H7/08
Filed: 1993-01-29
Granted: 1997-05-28
Abstract: A belt tensioning system, a belt tensioner therefor and methods of making the same are provided, the belt tensioning system comprising a tensioner arm pivotally mounted to a support, and a wound coiled spring having opposed ends one of which is operatively interconnected to an abutment of the support and the other of which is operatively interconnected to the arm, the arm having a shoulder for being engaged by the one of the opposed ends of the wound coiled spring so as to permit removal of the arm and the wound coiled spring as a self-contained unit from the support when the arm is pivoted to a certain position where the shoulder of the arm engages the one end of the spring and effectively moves the one end of the wound coiled spring out of contact with the abutment of the support.
Patent DE-69328442-D1 (DE)
Inventor: ABRAHMSEN LARS
IPC: C07K14/775
Filed: 1993-12-09
Granted: 2000-05-25
Abstract: PCT No. PCT/SE93/01061 Sec. 371 Date Aug. 25, 1995 Sec. 102(e) Date Aug. 25, 1995 PCT Filed Dec. 9, 1993 PCT Pub. No. WO94/13819 PCT Pub. Date Jun. 23, 1994The invention relates to an expression system giving high extracellular production of apolipoprotein AI-M (Milano) using E. coli and comprises a plasmid carrying an origin of replication, an inducible promoter sequence, a DNA sequence coding for a signal peptide, a DNA sequence coding for apolipoprotein AI-M, and a transcription terminator. The invention also relates to a method of producing apolipoprotein AI-M using the expression system.
Patent DE-69330252-D1 (DE)
Inventor: COHEN IRUN R
IPC: A61P43/00
Filed: 1993-11-09
Granted: 2001-06-28
Abstract: Substances comprising a N-sulfated or N-acetylated or non-sulfated N-acetylated 4-deoxy-4-en-iduronoglucosamine in substantially purified form, including compositions containing same and their uses are disclosed for the regulation of cytokine activity in a host. For instance, the secretion of Tumor Necrosis Factor Alpha (TNF- alpha ) can be either inhibited or augmented selectively by administration to the host of effective amounts of substances or their compositions comprising specific oligosaccharides in substantially purified form, in relation to the treatment or prevention of a medical condition which is selected from the group consisting of insulin-dependent diabetes mellitus, periodontal disease, inflammatory bowel disease, skin diseases, uveitis, rheumatic diseases, chronic inflammation, multiple sclerosis, lupus erythematosus, atherosclerosis, arthritis, vasculitis, allergy and neoplasia. The invention also relates to the initiation of a desirable immune system-related response by the host to the presence of activators, including pathogens, including viral infection, bacterial infection or fungal infection. <IMAGE>
Patent DE-69330558-D1 (DE)
Inventor: PY DANIEL
IPC: A61F9/00
Filed: 1993-03-12
Granted: 2001-09-13
Abstract: A cartridge for actuating a piston-like or accordion-like dispenser-vial for applying medicament to an eye. The cartridge includes a housing for holding the dispenser-vial and a telescoping cylinder for compressing the dispenser-vial in the longitudinal direction to actuate the vial. The cartridge includes a locking mechanism for locking the telescoping cylinder to restrict its movement and a trigger mechanism for releasing the cylinder from the locked position so that a drop is released from the dispenser. The housing includes a finger for engaging the lower eyelid and exposing the conjunctival cul de sac.
Patent DE-69333664-D1 (DE)
Inventor: MOED MICHAEL C
IPC: G06T7/00
Filed: 1993-06-18
Granted: 2004-11-18
Abstract: A method for adjusting a neuron encompassing a plurality of feature vectors comprises the steps of characterizing the spatial distribution of said feature vectors, and spatially adjusting said neuron in accordance with the characterization of step (a). An apparatus for adjusting a neuron encompassing a plurality of feature vectors comprises characterizing means for characterizing the spatial distribution of said feature vectors, and adjusting means for spatially adjusting said neuron in accordance with the characterization by said characterizing means. <IMAGE>
Patent DE-69334155-D1 (DE)
Inventor: LADANT DANIEL
IPC: C07K14/005
Filed: 1993-04-21
Granted: 2007-09-06
Abstract: A recombinant plasmid comprises the cyaC and the cyaA genes of Bordetella which directs the expression of Bordetella, adenylate cyclase in a transformed host cell. A recombinant DNA molecule can comprise the Bordetella cyaA gene containing at least one insertion of a heterologous DNA sequence at at least one permissive site. In addition, a recombinant Bordetella adenylate cyclase comprises a heterologous epitope at a permissive site. Methods of inducing a specific B cell, helper T cell, and CTL cell immune response are provided.
Patent DE-69411916-D1 (DE)
Inventor: ERICSON KURT
IPC: B29C45/14
Filed: 1994-06-03
Granted: 1998-08-27
Abstract: A valve head includes an annular valving plate made of a resilient material and a valve guide including projecting legs with elongated slots designed to couple with fins located on the valve body to provide valve guidance between open and closed positions. The valving plate and valve guide are assembled together by heating them to a sufficient temperature to permit a thin layer of the guide to melt and fuse with the valving plate.
Patent DE-69414822-D1 (DE)
Inventor: KAEGEBEIN DANIEL P
IPC: H03F1/52
Filed: 1994-09-02
Granted: 1999-01-07
Abstract: The amplifier system includes an input transmission line, an output transmission line, a primary amplifier circuit, a backup amplifier circuit, a bypass circuit. An amplifier switching device is used for mutually exclusively connecting the primary amplifying circuit, the backup amplifying circuit and the bypass circuit between the input and output transmission lines. The system also incorporates a device for generating a primary failure signal in response to an abnormal current draw of the primary amplifier. The amplifier switching device includes a device for automatically disconnecting the primary amplifier from the input and output transmission lines in response to the primary failure signal.
Patent DE-69415376-D1 (DE)
Inventor: HONDA SUSUMU
IPC: C04B24/32
Filed: 1994-04-05
Granted: 1999-02-04
Abstract: A cement admixture which when added to a cement composition, such as cement mortar or concrete inhibits slump-loss of the cement composition and improve its workability and applicability. The admixture is composed of copolymers from an alkenyl ether, a polyalkenyl ether and maleic anhydride.
Patent DE-69423492-D1 (DE)
Inventor: MARTIN GARY
IPC: B01D46/04
Filed: 1994-07-07
Granted: 2000-04-20
Abstract: Gas with entrained particles, such as high temperature and pressure gas from a pressurized circulating fluidized bed reactor, is filtered using a vessel having a gas inlet, cleaned gas outlet, and filtered particles outlet. A pulse of cleaning gas is periodically or intermittently directed to the filters to dislodge particles which have been filtered and collected on the filters. Shrouds, having tubular, parallelepiped, zig-zag, or honeycomb configurations, are provided surrounding relevant portions of the filters to prevent dislodged particles from being entrained in gas passing to other filters, and instead directing the dislodged particles toward the vessel particles outlet. The shroud walls may have openings in them which allow gas to be filtered to pass through them, but prevent dislodged particles from passing through the openings. The filters may be mounted in hollow tubular or parallelepiped ducts in such a way that the ducts have smooth outer walls, and the shrouds may be substantially concentric with the ducts. When individual cleaning gas pulsing devices are associated with filters, the shrouds may include separate impingement and material collecting portions.
Patent DE-69424301-D1 (DE)
Inventor: WOSKOV P
IPC: G01N21/68
Filed: 1994-10-24
Granted: 2000-06-08
Abstract: Microwave-induced plasma for continuous, real time trace element monitoring under harsh and variable conditions. The sensor includes a source of high power microwave energy and a shorted waveguide made of a microwave conductive, refractory material communicating with the source of the microwave energy to generate a plasma. The high power waveguide is constructed to be robust in a hot, hostile environment. It includes an aperture for the passage of gases to be analyzed and a spectrometer is connected to receive light from the plasma. Provision is made for real time in situ calibration. The spectrometer disperses the light, which is then analyzed by a computer. The sensor is capable of making continuous, real time quantitative measurements of desired elements, such as the heavy metals lead and mercury.
Patent DE-69426190-D1 (DE)
Inventor: MARGULIS WALTER
IPC: G02B6/28
Filed: 1994-08-15
Granted: 2000-11-30
Abstract: PCT No. PCT/SE94/00745 Sec. 371 Date Jun. 14, 1995 Sec. 102(e) Date Jun. 14, 1995 PCT Filed Aug. 15, 1994 PCT Pub. No. WO95/05617 PCT Pub. Date Feb. 23, 1995An optical device includes a waveguide and a film or layer of a material having highly nonlinear optical characteristics, in particular a semiconductor material. The film is located so close to the waveguide core that the evanescent field of light propagating along the waveguide extends up to the film. In this optical device, the large nonlinear properties of the material influence the optical characteristics of the waveguide. When positioned along a similar D-fiber, the device can be used as a fiber-based, nonlinear coupler controlled by a relatively weak light signal. The same device can be used as an element of a laser and in a number of various other applications.
Patent DE-69433091-D1 (DE)
Inventor: COLLER BARRY S
IPC: C12R1/91
Filed: 1994-11-07
Granted: 2003-10-02
Abstract: Platelet-specific, chimeric immunoglobulin and immunoglobulin fragments are described. The chimeric molecules are made up of a nonhuman antigen binding region and a human constant region. Preferred immunoglobulins are specific for glycoprotein IIb/IIIa receptor in its complexed form; they block ligand binding to the receptor and prevent platelet aggregation. The immunoglobulins can be used to reduce or prevent occlusion, reocclusion (e.g, abrupt closure), stenosis and/or restenosis. In addition, the immunoglobulins are useful in anti-thrombotic therapy when administered alone or in conjunction with thrombolytic agents, as well as in thrombus imaging.
Patent DE-69434682-D1 (DE)
Inventor: BAYLEY GWAIN
IPC: H04M11/00
Filed: 1994-11-14
Granted: 2006-05-18
Abstract: A method of invoking and canceling voice and data service between a mobile unit and a base station. Using a standard telephone system, the connection for a voice service and a data service is the same. With the introduction of the digital wireless link, the voice connection and the data connection are different. Therefore new dialing commands which indicate the intent of the connection are created. These commands can also be used to designate the intent of the call from a mobile unit capable of data and voice service but not capable of simultaneous voice and data service. They can also be used to invoke simultaneous voice and data services.
Patent DE-69523821-D1 (DE)
Inventor: MANDRALIS ZENON IOANNIS
IPC: A23G1/56
Filed: 1995-04-26
Granted: 2001-12-20
Abstract: A process for improving the heat resistance of chocolate or chocolate type products so that they have a reduced tendency to deform at elevated temperatures which comprises mixing a polyol gel or a polyol/water gel product in particulate form with a flowable mixture of chocolate type ingredients in an amount to achieve a polyol content of from 0.2 to 60% by weight based on the total amount of the resultant chocolate.
Patent DE-69525366-D1 (DE)
Inventor: ROSENBAUM SUSAN
IPC: G01N33/566
Filed: 1995-10-30
Granted: 2002-03-21
Abstract: The present invention relates to a method for determining whether a compound is capable of binding to a BMP receptor kinase protein complex, the method comprising introducing a sample comprising the compound to the BMP receptor kinase protein complex and allowing the compound to bind to the BMP receptor kinase protein complex, wherein the BMP receptor kinase protein complex is comprised of a BMP type I receptor kinase protein and the BMP receptor kinase protein BRK-3. The invention further relates to a method for determining the concentration of a BMP receptor ligand in a clinical sample, the met-hod comprising introducing the sample comprising the ligand to a BMP receptor kinase protein complex and allowing the ligand to bind to the BMP receptor kinase protein complex, wherein the BMP receptor kinase protein complex is comprised of a BMP type I receptor kinase protein and BMP receptor kinase protein BRK-3. The invention further relates to a host cell co-transfected with an expression vector comprising a DNA sequence that codes for the BMP receptor kinase protein BRK-3 and an expression vector comprising a DNA sequence that codes for a BMP type I receptor kinase protein. The invention further relates to a host cell co-transfected with an expression vector comprising a DNA sequence that codes for a soluble or incomplete BMP type I receptor kinase protein and a soluble or incomplete BMP receptor kinsase protein BRK-3. The invention further relates to a method for determining whether a test compound produces a signal upon binding to a BMP receptor protein complex.
Patent DE-69531301-D1 (DE)
Inventor: SHIH C
IPC: C12N15/09
Filed: 1995-05-05
Granted: 2003-08-21
Abstract: An isolated DNA encoding a keratinase is disclosed. The isolated DNA may be any of (a) isolated DNA which encodes the Bacillus licheniformis PWD-1 keratinase enzyme of FIG. 1, (b) isolated DNA which hybridizes to an oligonucleotide probe, which hybridizes to the DNA of (a) above, and does not hybridize to DNA encoding the Bacillus licheniformis NCIB 6816 subtilisin Carlsberg serine protease, and (c) isolated DNA differing from the isolated DNAs of (a) and (b) above in nucleotide sequence due to the degeneracy of the genetic code, and which encodes a keratinase enzyme.
Patent DE-69535533-D1 (DE)
Inventor: TUURENHOUT MATTHIJS WILLEM FRE
IPC: G01N27/447
Filed: 1995-09-29
Granted: 2007-08-23
Abstract: The invention relates to a gel cassette, comprising two glass plates and a substantially H- or U-shaped spacer. One of the two glass plates is preferably provided with sensors for measuring at least one gel parameter, such as the potential or the temperature. The spacer consists for instance of two part placed vertically in the situation of use which are mutually connected by means of a part lying substantially perpendicular thereto and substantially horizontal in the situation of use, wherein the horizontal part is provided with teeth. The invention further relates to the spacer, a glass plate for use in an electrophoresis cassette provided with sensors for measuring one or more gel parameters, an electrohporesis apparatus comprising a buffer container consisting of an upper buffer compartment and a lower buffer compartment, power points for applying a voltage between the upper buffer compartment and the lower buffer compartment and integral means for flushing a remaining space between the glass plates under the gel, and an assembly of a gel cassette and an electrophoresis apparatus according to the invention.
Patent DE-69609194-D1 (DE)
Inventor: MONTEZINOS LEE
IPC: A23F3/16
Filed: 1996-12-09
Granted: 2000-08-10
Abstract: A beverage such as a dilute juice or tea beverage having a stable flavor/cloud emulsion that contains from about 0.005 to about 0.015% xanthan gum, from about 100 ppm to about 1000 ppm of a preservative which can be sorbic acid, benzoic acid and, alkali metal salts thereof and mixtures thereof, from about 300 ppm to about 3000 ppm of a food grade water soluble polyphosphate, and from about 60 to about 99% by weight of added water having from 0 ppm to about 180 ppm of hardness.
Patent DE-69611323-D1 (DE)
Inventor: HILL GREGORY A
IPC: B29C45/00
Filed: 1996-03-29
Granted: 2001-02-01
Abstract: The present process is directed to making a contact lens using the RIM process.
Patent DE-69613704-D1 (DE)
Inventor: BOECKELER HENRY
IPC: C08C19/38
Filed: 1996-08-14
Granted: 2001-08-09
Abstract: A method for producing esters of hydroxy terminated polybutadiene, including the steps of: (a) providing an anhydride; (b) reacting a hydroxy terminated polybutadiene with the anhydride to form a carboxyl terminated polybutadiene derivative; (c) reacting the derivative with an epoxide. Also a curable composition, including: (a) an ester of hydroxy terminated polybutadiene; (b) a copolymerizable ethylenically unsaturated monomer; and (c) a drier.
Patent DE-69614393-D1 (DE)
Inventor: BURKE LYN
IPC: C12Q1/70
Filed: 1996-06-20
Granted: 2001-09-20
Abstract: Novel methods and immunodiagnostic test kits for diagnosing herpes simplex virus (HSV) infection are disclosed. The methods and kits employ both type-specific and type-common antigens, in a single-step assay format, to provide for highly accurate results. The methods discriminate between HSV-1 and HSV-2 infection so that an accurate diagnosis can be performed.
Patent DE-69623448-D1 (DE)
Inventor: SHEPLER STEWART
IPC: C08G18/65
Filed: 1996-02-27
Granted: 2002-10-10
Abstract: The present invention relates to coating compositions comprising (A) at least one binder containing hydroxyl groups, (B) at least one crosslinking agent and (C) at least one aromatic mono- and/or polycarboxylic acid and/or at least anhydride of an aromatic mono- and/or polycarboxylic acid.
Patent DE-69628346-D1 (DE)
Inventor: DE LA TORRE ROGER A
IPC: A61B19/08
Filed: 1996-09-27
Granted: 2003-06-26
Abstract: A flexible, fluid tight envelope (278) (324) (364) provides access for a hand and surgical instruments through a body tissue incision while maintaining insufflation pressure or a pneumoperitoneum within the body. The envelope is transparent and has an internal volume with opposite proximal and distal ends. A first opening in the envelope at the proximal end adjoins the incision and is secured and sealed to the body tissue. The second opening at the envelope distil end is provided with a closure member (350) that seals closed the second opening on itself or around the forearm of a surgeon or a surgical instrument inserted therein. An access port (284) (292) is provided at the first opening. The access port includes a housing (250) (290) (362) containing a valve element (282) Ä300) (392) that can be selectively opened and closed to provide access to the incision while maintaining insufflation pressure in the body cavity. <IMAGE>
Patent DE-69631014-D1 (DE)
Inventor: BINI ALESSANDRA
IPC: A61P7/00
Filed: 1996-05-17
Granted: 2004-01-22
Abstract: The invention provides a method of causing the degradation of fibrin(ogen) (i.e., fibrin, fibrinogen, and related substances) by means of a fibrinolytic metalloproteinase, such as MMP-3. The method of the invention may be performed in vitro to provide diagnostic information characterizing fibrin(ogen) and the fibrinolytic physiology. The method may also be performed in vivo as a method of thrombolytic therapy in which a fibrinolytic metalloproteinase is administered to a subject to degrade thrombus in situ. The invention further provides compositions containing a fibrinolytic metalloproteinase for the performance of fibrinolytic or thrombolytic procedures. Also provided are kits which include a fibrinolytic metalloproteinase for performing fibrinolytic or thrombolytic procedures.
Patent DE-69635452-D1 (DE)
Inventor: SEED BRIAN
IPC: C12N15/85
Filed: 1996-09-20
Granted: 2005-12-22
Abstract: The invention features a synthetic gene encoding a protein normally expressed in a mammalian cell or eukaryotic cell wherein at least one non-preferred or less preferred codon in the natural gene encoding the mammalian protein has been replaced by a preferred codon encoding the same amino acid.